Pennant Capital’s 3rd Quarter $700 Million Investments in Healthcare Stocks

Wall St. Watchdog reveals information regarding Pennant Capital Management’s top holdings in the Healthcare sector for the quarter ending September 30th, 2011. The firm held 8 stocks in the Healthcare sector at the end of the quarter with an aggregate market value of $700.656 million.

  • Davita Inc. (NYSE:DVA): On 06/30/2011, Pennant Capital Management reported holding 3,131,038 shares with a market value of $271,179,203. This comprised 5.84% of the total portfolio. On 09/30/2011, Pennant Capital Management reported holding 3,232,787 shares with a market value of $202,598,755. This comprised 5.02% of the total portfolio. The net change in shares for this position over the two quarters is 101,749. About Company: DaVita, Inc. provides dialysis services in the United States for patients suffering from chronic kidney failure. The Company treats patients through a network of owned and managed dialysis facilities in the continental United States.
  • Wellpoint Inc. (NYSE:WLP): On 06/30/2011, Pennant Capital Management reported holding 2,880,976 shares with a market value of $226,934,470. This comprised 4.89% of the total portfolio. On 09/30/2011, Pennant Capital Management reported holding 2,600,976 shares with a market value of $169,791,710. This comprised 4.21% of the total portfolio. The net change in shares for this position over the two quarters is -280,000. About Company: WellPoint Inc. is a health benefits company. The Company provides health benefits, dental and vision benefits, pharmacy benefits, life insurance, and life and disability insurance benefits. WellPoint operations include Blue Cross and Blue Shield plans.
  • Unitedhealth Group Inc. (NYSE:UNH): On 06/30/2011, Pennant Capital Management reported holding 3,251,419 shares with a market value of $167,708,198. This comprised 3.61% of the total portfolio. On 09/30/2011, Pennant Capital Management reported holding 2,851,419 shares with a market value of $131,507,441. This comprised 3.26% of the total portfolio. The net change in shares for this position over the two quarters is -400,000. About Company: UnitedHealth Group Incorporated owns and manages organized health systems in the United States and internationally. The Company provides employers products and resources to plan and administer employee benefit programs. UnitedHealth also serves the health needs of older Americans, provides specialized care services, and provides health care information and research to providers and payers.
  • Pfizer Inc. (NYSE:PFE): On 06/30/2011, Pennant Capital Management reported holding 4,983,329 shares with a market value of $102,656,579. This comprised 2.21% of the total portfolio. On 09/30/2011, Pennant Capital Management reported holding 4,983,329 shares with a market value of $88,105,258. This comprised 2.19% of the total portfolio. The net change in shares for this position over the two quarters is 0. About Company: Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company’s products include prescription pharmaceuticals, non-prescription self-medications, and animal health products such as anti-infective medicines and vaccines.
  • Hologic Inc. (NASDAQ:HOLX): On 06/30/2011, Pennant Capital Management reported holding 3,825,174 shares with a market value of $77,153,760. This comprised 1.66% of the total portfolio. On 09/30/2011, Pennant Capital Management reported holding 3,825,174 shares with a market value of $58,180,897. This comprised 1.44% of the total portfolio. The net change in shares for this position over the two quarters is 0. About Company: Hologic, Inc. develops, manufactures, and markets x-ray systems. The Company makes x-ray bone densitometers that measure the precise bone density for use in the diagnosing of metabolic bone diseases such as osteoporosis.
  • Amgen Inc. (NASDAQ:AMGN): On 06/30/2011, Pennant Capital Management reported holding 345,000 shares with a market value of $20,130,749. This comprised 0.43% of the total portfolio. On 09/30/2011, Pennant Capital Management reported holding 428,506 shares with a market value of $23,550,689. This comprised 0.58% of the total portfolio. The net change in shares for this position over the two quarters is 83,506. About Company: Amgen Inc. discovers, develops, manufactures, and markets human therapeutics based on cellular and molecular biology. The Company focuses its research on secreted protein and small molecule therapeutics, with particular emphasis on neuroscience and cancer. Amgen concentrates on the areas of hematology, cancer, infectious disease, endocrinology, neurobiology, and inflammation.
  • Quest Diagnostics Inc. (NYSE:DGX): On 06/30/2011, Pennant Capital Management reported holding 500,000 shares with a market value of $29,549,999. This comprised 0.64% of the total portfolio. On 09/30/2011, Pennant Capital Management reported holding 440,000 shares with a market value of $21,718,400. This comprised 0.54% of the total portfolio. The net change in shares for this position over the two quarters is -60,000. About Company: Quest Diagnostics Incorporated provides diagnostic testing, information, and services. The Company operates a national network of full-service laboratories, rapid response laboratories, and patient service centers. Quest Diagnostics provides esoteric testing, routine medical testing, drugs of abuse testing, and non-hospital-based anatomicpathology testing.
  • Human Genome Sciences Inc. (NASDAQ:HGSI): On 06/30/2011, Pennant Capital Management reported holding 0 shares. On 09/30/2011, Pennant Capital Management reported holding 410,000 shares with a market value of $5,202,900. This comprised 0.13% of the total portfolio. The net change in shares for this position over the two quarters is 410,000. About Company: Human Genome Sciences, Inc. researches and develops proprietary pharmaceutical and diagnostic products. The Company’s products predict, prevent, detect, treat, and cure disease based on the discovery of human and microbial genes.

(Note: Data regarding Pennant Capital Management’s stock holdings are sourced from whalewisdom.com. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>